Lhasa Limited shared knowledge shared progress

Management of N-Nitrosamines - Use of Mirabilis based purge calculations to understand MI related risk and control strategy options

pdf fileTeasdale A;

This presentation was given by Dr Andrew Teasdale, Senior Principal Scientist at AstraZeneca, as part of the 'Risk Assessment and Regulatory Decision Making for Alkyl Nitrosamines' webinar, on Tuesday 21st January 2020. 


© 2020 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.